Plastic Surgery · Santa Ana, CA
NPI
1225258965
Since 2007
Specialty
Plastic Surgery
Code 208200000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1945 E 17th St Ste 107
Santa Ana, CA, 92705
Phone (714) 500-7714
Medicare paid, 2024
$330K
10,425 services
Medicare patients, 2024
301
Average age 73
Drug cost, 2024
$2.0M
18,730 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Heidi Regenass was code 95004 (test - miscellaneous), 7,620 times for 99 patients. In total Heidi Regenass billed 10,425 services in 50 codes, and Medicare paid $330K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-02-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95004 Test - Miscellaneous | Office | 7,620 | 99 | $3.25 | $25K |
| G0181 Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 195 | 94 | $84.89 | $17K |
| 99204 Office E&M - New | Office | 162 | 162 | $141.45 | $23K |
| 36415 Venipuncture Blood Collection | Office | 147 | 145 | $8.65 | $1,272 |
| 94060 Pulmonary Function Testing | Office | 129 | 129 | $35.32 | $4,556 |
| 96116 Behavioral Health Services | Office | 129 | 129 | $77.57 | $10K |
| 93000 Electrocardiogram | Office | 125 | 125 | $12.01 | $1,501 |
| 93924 Duplex Scan - Extremity Arteries | Office | 124 | 124 | $145.58 | $18K |
| 76700 Ultrasound - Abdomen and Pelvis | Office | 119 | 118 | $104.75 | $12K |
| 93923 Duplex Scan - Extremity Arteries | Office | 117 | 117 | $112.22 | $13K |
| 94200 Pulmonary Function Testing | Office | 113 | 113 | $13.56 | $1,532 |
| 94729 Pulmonary Function Testing | Office | 110 | 110 | $51.96 | $5,716 |
| 93306 Echocardiography (TTE/TEE) | Office | 102 | 102 | $176.69 | $18K |
| 94726 Pulmonary Function Testing | Office | 91 | 91 | $50.92 | $4,634 |
| 94070 Pulmonary Function Testing | Office | 89 | 89 | $55.99 | $4,983 |
By year: 2022 $474K for 3,707 services; 2023 $317K for 1,885 services; 2024 $330K for 10,425 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 147 | 145 | $8.65 | $1,272 |
Medicare prescription drug claims, 2024
In 2024, the drug Heidi Regenass prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,328 prescriptions and refills. In total Heidi Regenass wrote 18,730 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,328 | 1,328 | 354 | $10K |
| Amlodipine Besylate Generic | 750 | 750 | 221 | $3,615 |
| Metformin Hcl Generic | 743 | 745 | 236 | $56K |
| Tamsulosin Hcl Generic | 576 | 578 | 156 | $5,968 |
| Omeprazole Generic | 539 | 539 | 146 | $3,474 |
| Losartan Potassium Generic | 482 | 484 | 119 | $3,342 |
| Levothyroxine Sodium Generic | 445 | 445 | 116 | $3,299 |
| Furosemide Generic | 420 | 420 | 128 | $1,389 |
| Lisinopril Generic | 401 | 404 | 125 | $2,277 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 399 | 439 | 142 | $12K |
| Gabapentin Generic | 379 | 381 | 145 | $4,048 |
| Pantoprazole Sodium Generic | 302 | 302 | 86 | $2,835 |
| Quetiapine Fumarate Generic | 270 | 270 | 72 | $3,916 |
| Jardiance Empagliflozin | 265 | 266 | 77 | $162K |
| Rosuvastatin Calcium Generic | 250 | 250 | 74 | $2,281 |
Brand drugs: 2,936 claims; generic drugs: 15,557 claims; opioid claims: 12.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Heidi Regenass were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.